Avadel Pharmaceuticals PLC (AVDL NASDAQ) stock market data APIs
$21.3828
1.29(6%)
as of November 26, 2025
Try our APIs with
free plan!
Avadel Pharmaceuticals PLC Financial Data Overview
Price chart is built with
Anychart
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is the LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of cataplexy or excessive daytime sleepiness in patients seven years of age and older with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin 2, Ireland.
Prev. Close
21.3828
Open
22.6721
High
22.8593
Low
21.2082
52 wk Range
6.38-23.57
Market Cap
2 097 M
P/E Ratio
0
Shares Outstanding
97 991 K
Revenue
249 M
EPS
0.0002
Beta
1.632
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Avadel Pharmaceuticals PLC (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Avadel Pharmaceuticals PLC data using free add-ons & libraries
Get Avadel Pharmaceuticals PLC Fundamental Data
Avadel Pharmaceuticals PLC Fundamental data includes:
- Net Revenue: 249 M
- EBITDA: 2 699 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: 0.0763
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Avadel Pharmaceuticals PLC News
New
Avadel (AVDL) Drops 6.7% on Lack of Leads
We recently published 10 Stocks Losing Their Bite Before Thanksgiving. Avadel Pharmaceuticals plc (NASDAQ:AVDL) is one of the worst-performing stocks on Wednesday. Avadel declined by 6.67 percent on ...
ALKS Raises Its Offer to Buy Avadel In Response to Lundbeck's Proposal
Alkermes ALKS announced that it has now increased the offer to acquire Ireland-based Avadel Pharmaceuticals AVDL in a deal valued at up to $22.50 per share, representing a total transaction value of a...
3 Prominent Stocks Estimated To Be Up To 35.1% Below Intrinsic Value
As the U.S. stock market shows signs of recovery with major indexes snapping recent losing streaks, investors are keeping a close watch on tech giants like Nvidia for insights into broader market tren...
Alkermes Ups Its Avadel Bid To $2.37 Billion In A Buyout Battle With Lundbeck
Alkermes upped its bid on Avadel to $2.37 billion on Wednesday, coming in with the "superior proposal" vs. Lundbeck's unexpected pitch. Continue Reading View Comments
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
